BioInvent International AB (publ) (LON:0H22)

LON:0H22 Statistics

Total Valuation

LON:0H22 has a market cap or net worth of GBP 154.61 million. The enterprise value is 92.44 million.

Market Cap	154.61M
Enterprise Value	92.44M

Important Dates

The last earnings date was Tuesday, August 26, 2025.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	65.80M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	30.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.92
PB Ratio	2.48
P/TBV Ratio	2.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.13
EV / Sales	4.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.71

Financial Position

The company has a current ratio of 8.59, with a Debt / Equity ratio of 0.02.

Current Ratio	8.59
Quick Ratio	8.49
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-579.95

Financial Efficiency

Return on equity (ROE) is -30.60% and return on invested capital (ROIC) is -20.74%.

Return on Equity (ROE)	-30.60%
Return on Assets (ROA)	-19.02%
Return on Invested Capital (ROIC)	-20.74%
Return on Capital Employed (ROCE)	-39.52%
Revenue Per Employee	159,986
Profits Per Employee	-183,682
Employee Count	114
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0H22 has paid 16,503 in taxes.

Income Tax	16,503
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.14% in the last 52 weeks. The beta is -0.10, so LON:0H22's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-30.14%
50-Day Moving Average	35.50
200-Day Moving Average	33.09
Relative Strength Index (RSI)	38.26
Average Volume (20 Days)	1,049

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0H22 had revenue of GBP 19.52 million and -22.41 million in losses. Loss per share was -0.34.

Revenue	19.52M
Gross Profit	19.52M
Operating Income	-24.71M
Pretax Income	-22.39M
Net Income	-22.41M
EBITDA	-23.80M
EBIT	-24.71M
Loss Per Share	-0.34

Balance Sheet

The company has 61.21 million in cash and 993,528 in debt, giving a net cash position of 60.22 million.

Cash & Cash Equivalents	61.21M
Total Debt	993,528
Net Cash	60.22M
Net Cash Per Share	n/a
Equity (Book Value)	62.23M
Book Value Per Share	0.95
Working Capital	59.45M

Cash Flow

In the last 12 months, operating cash flow was -19.08 million and capital expenditures -535,295, giving a free cash flow of -19.62 million.

Operating Cash Flow	-19.08M
Capital Expenditures	-535,295
Free Cash Flow	-19.62M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -126.58% and -114.81%.

Gross Margin	100.00%
Operating Margin	-126.58%
Pretax Margin	-114.73%
Profit Margin	-114.81%
EBITDA Margin	-121.91%
EBIT Margin	-126.58%
FCF Margin	n/a

Dividends & Yields

LON:0H22 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-14.49%
FCF Yield	-12.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 14, 2020. It was a reverse split with a ratio of 0.04.

Last Split Date	Dec 14, 2020
Split Type	Reverse
Split Ratio	0.04

Scores

Altman Z-Score	n/a
Piotroski F-Score	2